Jade Biosciences (JBIO) Shares Outstanding (2020 - 2026)
Jade Biosciences (JBIO) posted Shares Outstanding (Entity) of $828102.0 for Q1 2025, little changed on a QoQ basis from $828102.0 in Q4 2024, and up 3.89% year-over-year from $797068.0 in Q1 2024.
Jade Biosciences (JBIO) Shares Outstanding (2020 - 2026) Analysis & Trends
Jade Biosciences' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $828102.0 for Q1 2025.
- Quarterly Shares Outstanding (Entity) rose 3.89% year-over-year to $828102.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $828102.0 (up 3.89% YoY) and the FY2024 annual result came in at $828102.0, up 4.4% from the prior year.
- Shares Outstanding (Entity) was $828102.0 for Q1 2025 at Jade Biosciences, roughly flat from $828102.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $828102.0 in Q4 2024 and bottomed at $351229.0 in Q4 2021.
- A 5-year average of $735558.3 and a median of $788563.0 in 2023 frame the typical range for Shares Outstanding (Entity).
- Peak annual rise in Shares Outstanding (Entity) reached 101.1% in 2022, while the deepest fall reached 0.39% in 2022.
- Jade Biosciences' Shares Outstanding (Entity) stood at $351229.0 in 2021, then soared by 101.1% to $706335.0 in 2022, then climbed by 12.3% to $793180.0 in 2023, then grew by 4.4% to $828102.0 in 2024, then changed by 0.0% to $828102.0 in 2025.
- Business Quant data shows JBIO's Shares Outstanding (Entity) at $828102.0 in Q1 2025, $828102.0 in Q4 2024, and $824751.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 57.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.78 Mn |
| Dec 31, 2025 | 31.36 Mn |
| Sep 30, 2025 | 39.58 Mn |
| Jun 30, 2025 | 28.43 Mn |
| Mar 31, 2025 | 828,102.00 |
| Dec 31, 2024 | 816,593.00 |
| Sep 30, 2024 | 824,625.00 |
| Jun 30, 2024 | 821,560.00 |
| Mar 31, 2024 | 794,127.00 |
| Dec 31, 2023 | 752,295.00 |
| Sep 30, 2023 | 789,690.00 |
| Jun 30, 2023 | 719,007.00 |
| Mar 31, 2023 | 707,903.00 |
| Dec 31, 2022 | 699,168.00 |
| Sep 30, 2022 | 698,673.00 |
| Jun 30, 2022 | 697,408.00 |
| Mar 31, 2022 | 697,405.00 |
| Dec 31, 2021 | 351,229.00 |
| Sep 30, 2021 | 682,395.00 |
| Jun 30, 2021 | 6,945.00 |